TP53 and cancer: Selivanova and colleagues45 have previously shown that small-molecule RITA, a known p53 activator, promotes p53-mediated cell death in cancer cells by synthetic lethal mechanism converging on concurrent inhibition of thioredoxin reductase (TrxR), which results in elevated oxidative stress and inhibition of p53/MDM2 complex.